Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

70 results about "Accidental exposure" patented technology

Control of radiation injury

The invention relates to the field of drug development against acute radiation injury caused by exposure to high-energy electromagnetic waves (X-rays, gamma rays) or particles (alpha particles, beta particles, neutrons). To date, there is no effective drug to ameliorate radiation injury after accidental exposure to ionizing irradiation. The invention provides a method of treating radiation injury of a subject in need thereof comprising administering to the subject a peptide, or functional analogue or derivative thereof, of smaller than 30 amino acids. Furthermore, the invention provides use of a peptide, or functional analogue or derivative thereof, of smaller than 30 amino acids for the production of a pharmaceutical composition for the treatment of a subject suffering from or believed to be suffering from radiation injury. In particular, the invention provides anti-radiation peptides having a dose reduction factor (DRF) against acute gamma irradiation of at least 1.10, said DRF determinable by testing which dose of radiation results in 50% mortality at 30 days (LD50/30) after whole body radiation (WBI) in a test group of mice treated with said peptide at 72 hours after WBI and, testing which dose of radiation results in 50% mortality at 30 days (LD50/30) after whole body radiation (WBI) in a control group of mice treated only with the vehicle of said peptide at 72 hours after WBI and wherein the DRF is calculated by dividing the LD50/30 of the peptide-treated animals by the LD50/30 of the vehicle-treated animals.
Owner:BIOTEMPT

Control of radiation injury

The invention relates to the field of drug development against acute radiation injury caused by exposure to high-energy electromagnetic waves (X-rays, gamma rays) or particles (alpha particles, beta particles, neutrons). To date, there is no effective drug to ameliorate radiation injury after accidental exposure to ionizing irradiation. The invention provides a method of treating radiation injury of a subject in need thereof comprising administering to the subject a peptide, or functional analogue or derivative thereof, of smaller than 30 amino acids. Furthermore, the invention provides use of a peptide, or functional analogue or derivative thereof, of smaller than 30 amino acids for the production of a pharmaceutical composition for the treatment of a subject suffering from or believed to be suffering from radiation injury. In particular, the invention provides anti-radiation peptides having a dose reduction factor (DRF) against acute gamma irradiation of at least 1.10, said DRF determinable by testing which dose of radiation results in 50% mortality at 30 days (LD50 / 30) after whole body radiation (WBI) in a test group of mice treated with said peptide at 72 hours after WBI and, testing which dose of radiation results in 50% mortality at 30 days (LD50 / 30) after whole body radiation (WBI) in a control group of mice treated only with the vehicle of said peptide at 72 hours after WBI and wherein the DRF is calculated by dividing the LD50 / 30 of the peptide-treated animals by the LD50 / 30 of the vehicle-treated animals.
Owner:BIOTEMPT

Use of peptides for the control of radiation injury

The invention relates to the field of drug development against acute radiation injury caused by exposure to high-energy electromagnetic waves (X-rays, gamma rays) or particles (alpha particles, beta particles, neutrons). To date, there is no effective drug to ameliorate radiation injury after accidental exposure to ionizing irradiation. The invention provides a method of treating radiation injury of a subject in need thereof comprising administering to the subject a peptide, or functional analogue or derivative thereof, of smaller than 30 amino acids. Furthermore, the invention provides use of a peptide, or functional analogue or derivative thereof, of smaller than 30 amino acids for the production of a pharmaceutical composition for the treatment of a subject suffering from or believed to be suffering from radiation injury. In particular, the invention provides anti-radiation peptides having a dose reduction factor (DRF) against acute gamma irradiation of at least 1.10, said DRF determinable by testing which dose of radiation results in 50% mortality at 30 days (LD50/30) after whole body radiation (WBI) in a test group of mice treated with said peptide at 72 hours after WBI and, testing which dose of radiation results in 50% mortality at 30 days (LD50/30) after whole body radiation (WBI) in a control group of mice treated only with the vehicle of said peptide at 72 hours after WBI and wherein the DRF is calculated by dividing the LD5O/3O of the peptide-treated animals by the LD50/30 of the vehicle-treated animals.
Owner:BIOTEMPT

Medical Sharps Retardation Apparatus and a Method of Retarding Medical Sharps from Future Use

A medical apparatus whose purpose it is to permanently retard future use of a medical apparatus, in particular needles, preventing accidental exposure to contaminated sharps. It facilitates the possible removal of medical devices from their respective holders, while preventing possible contaminated discharge of fluids located along the anterior or exterior walls of needles or exterior of medical sharps. This medical apparatus provides for single handed use which complies with OSHA guidelines, and its advanced design facilitates the more common shorter medical needles to which non-medical users are accustomed as well as the wide range of needles that medical professional use. This apparatus is easier to manufacture, shorter in stature that allows for its inclusion in the already overcrowded medical trays used by today's medical personnel, in particular, emergency medical technicians. An embodiment contains multiple apparatuses together allowing for safe storage of several sharps, which is a common need in emergency situations both in the field and in the hospital settings, where doctors or technicians are attempting to stabilize critical patients with multiple injections. The apparatus uses counter-opposing gripping devices with an enveloping containment member which serves both to tension the juxtapositionally aligned gripping devices and to prevent leakage of contaminated fluids from medical devices.
Owner:GRIFF INDS

Medical sharps retardation apparatus and a method of retarding medical sharps from future use

A medical apparatus whose purpose it is to permanently retard future use of a medical apparatus, in particular needles, preventing accidental exposure to contaminated sharps. It facilitates the possible removal of medical devices from their respective holders, while preventing possible contaminated discharge of fluids located along the anterior or exterior walls of needles or exterior of medical sharps. This medical apparatus provides for single handed use which complies with OSHA guidelines, and its advanced design facilitates the more common shorter medical needles to which non-medical users are accustomed as well as the wide range of needles that medical professional use. This apparatus is easier to manufacture, shorter in stature that allows for its inclusion in the already overcrowded medical trays used by today's medical personnel, in particular, emergency medical technicians. An embodiment contains multiple apparatuses together allowing for safe storage of several sharps, which is a common need in emergency situations both in the field and in the hospital settings, where doctors or technicians are attempting to stabilize critical patients with multiple injections. The apparatus uses counter-opposing gripping devices with an enveloping containment member which serves both to tension the juxtapositionally aligned gripping devices and to prevent leakage of contaminated fluids from medical devices.
Owner:GRIFF INDS

Radioactive source pneumatic conveying control detection device

The invention belongs to the field of radioactive source application and particularly relates to a radioactive source pneumatic conveying control detection device. An existing radioactive source pneumatic conveying system cannot accurately control and determine the position of a radioactive source in the using process, and workers are subject to the risk of accidental exposure. The radioactive source pneumatic conveying control detection device comprises an air compressor connected with a radioactive source storage tank through an air flow conveying pipeline. A first air flow channel and a radioactive source channel which are communicated with each other are positioned in the radioactive source storage tank, the air flow conveying pipeline is connected with the first air flow channel of the radioactive source storage tank, the radioactive source channel of the radioactive source storage tank is connected with a radioactive source conveying pipe, a plurality of proximity switches for sensing the passage of a radioactive source are positioned outside the radioactive source conveying pipe; and the proximity switches are connected with a control system. The device can control conveying operation of the radioactive source, the position of the radioactive source in the operation process is accurately mastered, and the accidental exposure to the workers caused by unclearness of the position of the radioactive source is avoided.
Owner:CHINA INSTITUTE OF ATOMIC ENERGY

Exercising lactation bra capable of preventing accidental exposure

The invention discloses an exercising lactation bra capable of preventing accidental exposure. The exercising lactation bra comprises a cup, a chest bib and shoulder girdles which form a one-piece structure, wherein the inner and outer sides of the chest bib are skin-friendly layers, the middle of the chest bib is an elastic layer, and the chest bib is fixedly connected with the cup; two shaping bra pads are symmetrically arranged in the middle of the cup, vent holes are uniformly formed in the shaping bra pads, the top of the cup is movably connected with the shoulder girdles through hasps, reinforcing ribs are arranged at the top of the cup, and the lowest positions of the tops of the reinforcing ribs are not lower than 1 / 3 of the height of the cup. The exercising lactation bra is integrally of a one-piece rib fabric and is simple and elegant; by utilizing a high heart design, the volume is relatively large, displacement and accidental exposure of breasts are effectively avoided; byutilizing an exercising bra design, pregnant women who love sports are facilitated; the shoulder girdles are connected with internal support pieces to form a semicircle, so that external expansion ofthe chest can be prevented, meanwhile, the flexibility of the cup can be improved, and the supporting effect of the chests is remarkable; and by designing the hasps, the lactation is facilitated.
Owner:丹阳市艾妮宝贝服饰有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products